One Year Later: Family Members of Patients with COVID-19 Experience Persistent Symptoms of Posttraumatic Stress Disorder
Stress Disorders, Post-Traumatic
03 medical and health sciences
0302 clinical medicine
Critical Illness
Humans
COVID-19
Family
Prospective Studies
Original Research
DOI:
10.1513/annalsats.202209-793oc
Publication Date:
2022-12-12T17:31:00Z
AUTHORS (25)
ABSTRACT
Rationale: Family members of critically ill patients with coronavirus disease (COVID-19) have described increased symptoms posttraumatic stress disorder (PTSD). Little is known about how these may change over time. Objectives: We studied changes in PTSD family COVID-19 12 months. Methods: This prospective, multisite observational cohort study recruited participants at hospitals five states. Calls were made to 3–4 months, 6 and months after patient admission the intensive care unit. Results: There 955 eligible members, whom 330 (53.3% those reached) consented participate. Complete longitudinal data was acquired for 115 individuals (34.8% consented). measured by IES-6 (Impact Events Scale-6), a score least 10 identifying significant symptoms. At 3 mean 11.9 ± 6.1, 63.6% having symptoms, decreasing 32.9% 1 year (mean score, 7.6 5.0). Three clusters symptom evolution emerged time: persistent (34.8%, n = 40), recovered (33.0%, 38), nondevelopment (32.2%, 37). Although as Hispanic demonstrated initially higher adjusted scores (2.57 points [95% confidence interval (CI), 1.1–4.1; P < 0.001]), they also more dramatic improvement time (4.7 greater decrease CI, 3.2–6.3; 0.001]). Conclusions: One later, some continue experience PTSD. Further studies are needed better understand various differences contribute risk
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (32)
CITATIONS (5)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....